Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a prospective, open lable studies conducted in 115 hospital to compare between thromboectomy and Recombinant Tisue Plasminogen Activator only to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known. Although basilar artery occlusion has been reported in 2 per 1000 autopsy cases, basilar artery thrombosis may, in stroke registries, explain as many as 27% of ischemic strokes occurring in the posterior circulation.Various treatments were tried in groups of patients with vertebrobasilar territory infarction but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the eficacy and safety of endovascular treatment in basilar artery occlusion stroke patients
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Thromboectomy and rTPA | Experimental | use thromboectomy and rtpa for patient with basilar artery occlusion stroke in 24 hour |
|
| rTPA( recombinant tissue plasminogen activator ) | No Intervention | use rtpa for patient with basilar artery occlusion stroke in 24 hour |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Thromboectomy | Procedure | Thromboectomy in Basilar Artery Occlusion patients |
|
| Measure | Description | Time Frame |
|---|---|---|
| NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission | NIHSS in patients wtih Basilar Artery Occlusion Stroke after 24hour admission | 24 hours from admission |
| Survival rate in patients with Basilar Artery Occlusion Stroke | Survival rate in patients with Basilar Artery Occlusion Stroke | 3 months from admission |
| Measure | Description | Time Frame |
|---|---|---|
| mRS in patients with Basilar Artery Occlusion Stroke | mRS in patients with Basilar Artery Occlusion Stroke | 3 months from admission |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| DUNG U Tran Nguyen | Contact | 0902610832 | uyendungtrannguyen@gmail.com | |
| THANG H Nguyen, MD, PhD | Contact | 033962478 |
| Name | Affiliation | Role |
|---|---|---|
| TUAN D Tran, MD | UMP university | Study Chair |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D000083242 | Ischemic Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |